J Dugan, D Pollyea - Expert review of clinical pharmacology, 2018 - Taylor & Francis
ABSTRACT Introduction: In August 2017, the United States Federal Drug Administration
(FDA) approved enasidenib (Idhifa, Celgene/Agios) for adults with relapsed and refractory …